Zimmer Biomet announced its third-quarter 2024 financial results, reporting $1.824 billion in net sales and $249.1 million in net earnings. Despite challenges with their ERP implementation, the company highlighted their acquisition of OrthoGrid Systems Inc. for AI in total hip arthroplasty. President and CEO Ivan Tornos expressed pride in the team’s ability to manage these challenges and focus on innovation and new product introductions. Moving forward, Zimmer Biomet is committed to delivering on strategic priorities and advancing their mission to help improve the quality of life for millions of people suffering from pain.
Source link
Zimmer Biomet reports increased net sales in third-quarter 2024 financial results
